Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA furlough threat

Executive Summary

FDAers and other HHS employees have been told to show up for work on Oct. 9 although the threat of furloughs has been revived by the House of Representative's 254 to 179 vote against the budget summit agreement on Oct. 5. On the same day, the government's stopgap omnibus spending bill expired and President Bush said he would not sign another temporary funding bill unless a budget resolution is passed. HHS made preparations to furlough FDAers for about seven days a month in case the Gramm-Rudman law goes into effect, but the agency said it would not do so during the first two weeks of October.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS018166

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel